Skip to main content

Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid Receptors

  • Protocol
  • First Online:
Book cover Endocannabinoid Signaling

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1412))

Abstract

Cannabinoid CB1 and CB2 receptors are G-protein-coupled receptors (GPCRs) that recruit β-arrestins upon activation by (partial) agonists. β-Arrestin recruitment is induced by phosphorylation of their C-terminal tails, and is associated with the termination of GPCR signaling; yet, it may also activate cellular signaling pathways independent of G-proteins. Here, we describe a detailed protocol to characterize the potency and efficacy of ligands to induce or inhibit β-arrestin recruitment to the human CB1 and CB2 receptors, by using the PathHunter® assay. The latter is a cellular assay that can be performed in plates with 384-wells. The PathHunter® assay makes use of β-galactosidase complementation, and has a chemiluminescent readout. We used this assay to characterize a set of reference ligands (both agonists and antagonists) on human CB1 and CB2 receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rang HP, Dale MM, Ritter JM et al (2008) Rang and Dale’s pharmacology, 6th edn. Elsevier, Edinburgh

    Google Scholar 

  2. Hamm HE (1998) The many faces of G protein signaling. J Biol Chem 273:669–672

    Article  CAS  PubMed  Google Scholar 

  3. Shenoy SK, Drake MT, Nelson CD et al (2006) Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem 281:1261–1273

    Article  CAS  PubMed  Google Scholar 

  4. Whalen EJ, Rajagopal S, Lefkowitz RJ (2011) Therapeutic potential of β-arrestin- and G protein-biased agonists. Trends Mol Med 17:126–139

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Violin JD, Lefkowitz RJ (2007) Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 28:416–422

    Article  CAS  PubMed  Google Scholar 

  6. Atwood BK, Wager-Miller J, Haskins C et al (2012) Functional selectivity in CB2 cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB2 ligands. Mol Pharmacol 81:250–263

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bosier B, Muccioli GG, Hermans E et al (2010) Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. Biochem Pharmacol 80:1–12

    Article  CAS  PubMed  Google Scholar 

  8. Price MR (2005) Allosteric modulation of the cannabinoid CB1 receptor. Mol Pharmacol 68:1484–1495

    Article  CAS  PubMed  Google Scholar 

  9. Han S, Thatte J, Buzard DJ et al (2013) Therapeutic utility of cannabinoid receptor type 2 (CB2) selective agonists. J Med Chem 56:8224–8256

    Article  CAS  PubMed  Google Scholar 

  10. DiscoveRx.   http://www.discoverx.com/technologies-platforms/enzyme-fragment-complementation-technology/pathhunter-efc-cell-based-assay-platform/protein-protein-interactions/gpcrs-b-arrestin

  11. Zhang R, Xie X (2012) Tools for GPCR drug discovery. Acta Pharmacol Sin 33:372–384

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Patel A, Murray J, McElwee-Whitmer S et al (2009) A combination of ultrahigh throughput PathHunter and cytokine secretion assays to identify glucocorticoid receptor agonists. Anal Biochem 385:286–292

    Article  CAS  PubMed  Google Scholar 

  13. Van der Lee MMC, Blomenröhr M, van der Doelen AA et al (2009) Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1. J Biomol Screen 14:811–823

    Article  PubMed  Google Scholar 

  14. Van Der Lee MMC, Bras M, van Koppen CJ et al (2008) beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1. J Biomol Screen 13:986–998

    Article  Google Scholar 

  15. DiscoveRx.    http://www.discoverx.com/DiscoveRx/media/ContentFiles/DataSheets/93-0001L.pdf

  16. Yin H, Chu A, Li W et al (2009) Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem 284:12328–12338

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors wish to thank DiscoveRx for their technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laura H. Heitman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Soethoudt, M., van Gils, N., van der Stelt, M., Heitman, L.H. (2016). Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid Receptors. In: Maccarrone, M. (eds) Endocannabinoid Signaling. Methods in Molecular Biology, vol 1412. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3539-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3539-0_11

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-3537-6

  • Online ISBN: 978-1-4939-3539-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics